- On December 11, 2025, the U.S. Food and Drug Administration (FDA) issued a letter to the dietary supplement industry which clarifies the placement of the Dietary Supplement Health and Education
11th Circuit Rules for Plaintiffs in Class Action Lawsuit Based on Economic Loss From Purchase of ‘Worthless’ Supplements Containing DMBA – an Impermissible NDI
Posted on
- We previously reported on a flurry of FDA enforcement actions in 2015 based on adulteration per se, which followed years of relative inaction in the dietary supplement marketing arena outside
FDA to Strengthen Dietary Supplements Regulation
Posted on
- On February 11, FDA Commissioner Scott Gottlieb, M.D. announced a new plan for modernizing and strengthening dietary supplement regulation and oversight. In making the announcement, Dr. Gottlieb pointed out
…
Continue Reading FDA to Strengthen Dietary Supplements Regulation
FDA Announces October Meeting on Pre-DSHEA List
Posted on
- Manufacturers or distributors of new dietary ingredients (NDIs) must submit a pre-market notification called a new dietary ingredient notification (NDIN) to FDA at least 75 days before marketing a dietary
…
Continue Reading FDA Announces October Meeting on Pre-DSHEA List
Down on DMBA
Posted on
- By law, a “dietary ingredient” is defined as a vitamin; a mineral;
FDA Bumps BMPEA
Posted on
FDA takes enforcement action against BMPEA.
- In recent weeks, we have seen increased media coverage regarding concerns about beta-methylphenethylamine (BMPEA) in dietary supplements in the United States. Congressmen have urged